BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7053901)

  • 1. Comparison of synthetic and natural glucosylceramides as substrate for glucosylceramidase assay.
    Vaccaro AM; Kobayashi T; Suzuki K
    Clin Chim Acta; 1982 Jan; 118(1):1-7. PubMed ID: 7053901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The assay of glucocerebrosidase activity using the natural substrata.
    Strasberg PM; Lowden JA
    Clin Chim Acta; 1982 Jan; 118(1):9-20. PubMed ID: 7053909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of rates of hydrolysis of N-oleoyl and N-stearoyl glucocerebroside in patients with Gaucher's disease.
    Peters SP; Aquino L; Naccarato WF; Gilbertson JR; Diven WF; Glew RH
    Biochim Biophys Acta; 1979 Oct; 575(1):27-36. PubMed ID: 508779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of activator proteins for the enzymatic degradation of glucosylceramide in several human tissues.
    Vaccaro AM; Ciaffoni F; Mandara I; Suzuki K
    Clin Chim Acta; 1988 Mar; 172(2-3):323-34. PubMed ID: 3370844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system.
    Sarmientos F; Schwarzmann G; Sandhoff K
    Eur J Biochem; 1986 Nov; 160(3):527-35. PubMed ID: 3780720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of glucosylceramidase to glucosylceramide is promoted by its activator protein.
    Vaccaro AM; Muscillo M; Salvioli R; Tatti M; Gallozzi E; Suzuki K
    FEBS Lett; 1987 Jun; 216(2):190-4. PubMed ID: 3582671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydrogenation of glucosyl- and galactosylceramide on their enzymatic hydrolysis.
    Vaccaro AM; Muscillo M; Suzuki K
    Clin Chim Acta; 1983 Jun; 131(1-2):1-13. PubMed ID: 6883703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors and stimulators of glucocerebroside metabolism.
    Radin NS
    Prog Clin Biol Res; 1982; 95():357-83. PubMed ID: 6214799
    [No Abstract]   [Full Text] [Related]  

  • 9. Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients.
    Choy FY; Davidson RG
    Am J Hum Genet; 1980 Sep; 32(5):670-80. PubMed ID: 6775530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the activity of glucosylceramidase and its binding to glucosylceramide-containing liposomes. Role of acidic phospholipids and fatty acids.
    Vaccaro AM; Tatti M; Salvioli R; Ciaffoni F; Gallozzi E
    Biochim Biophys Acta; 1990 Jan; 1033(1):73-9. PubMed ID: 2302413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal and cellular models of Gaucher's disease. I. Refractoriness of thio analogs of glucocerebroside to enzymatic hydrolysis.
    Quirk JM; Weis AL; Shapiro D; Brady RO
    Biotechnol Appl Biochem; 1986 Feb; 8(1):96-100. PubMed ID: 3828086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebroside-beta-glucosidase activity in Gaucher brain.
    Svennerholm L; MÃ¥nsson JE; Rosengren B
    Clin Genet; 1986 Aug; 30(2):131-5. PubMed ID: 3757304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaucher's disease.
    Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahasrabudhe GS; Chole PV
    J Assoc Physicians India; 2009 May; 57():410-1. PubMed ID: 19634291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher's disease, a review.
    Peters SP; Lee RE; Glew RH
    Medicine (Baltimore); 1977 Sep; 56(5):425-42. PubMed ID: 329054
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical studies in a patient with subacute neuropathic Gaucher disease without visceral glucosylceramide storage.
    Wenger DA; Roth S; Kudoh T; Grover WD; Tucker SH; Kaye EM; Ullman MD
    Pediatr Res; 1983 May; 17(5):344-8. PubMed ID: 6856396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake by neuroblastoma cells of glucosylceramide, glucosylceramide glucosidase, its stimulator protein, and phosphatidylserine.
    Datta SC; Snider RM; Radin NS
    Biochim Biophys Acta; 1986 Jul; 877(3):387-98. PubMed ID: 3730407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the binding of glucosylceramidase to its natural substrate dispersion.
    Vaccaro AM; Tatti M; Ciaffoni F; Salvioli R
    Enzyme; 1989; 42(2):87-97. PubMed ID: 2591351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from glucosylceramide and Gaucher's disease.
    Luft FC
    J Mol Med (Berl); 1998 Oct; 76(11):723-4. PubMed ID: 9826117
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of membrane-bound glucosylceramide: beta-glucosidase in fibroblasts cultured from normal and glucosylceramidotic human skin.
    Mueller OT; Rosenberg A
    J Biol Chem; 1979 May; 254(9):3521-5. PubMed ID: 429368
    [No Abstract]   [Full Text] [Related]  

  • 20. Normalization of liver glucosylceramide levels in the "Gaucher" mouse by phosphatidylserine injection.
    Datta SC; Radin NS
    Biochem Biophys Res Commun; 1988 Apr; 152(1):155-60. PubMed ID: 3358758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.